# The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation

> **NCT02831894** · PHASE2 · COMPLETED · sponsor: **National Jewish Health** · enrollment: 74 (actual)

## Conditions studied

- Hypnotic Dependence Among Those With Insomnia

## Interventions

- **DRUG:** 0% Hypnotic Medication Taper
- **DRUG:** 25% Hypnotic Medication Taper
- **DRUG:** 10% Hypnotic Medication Taper

## Key facts

- **NCT ID:** NCT02831894
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-02
- **Primary completion:** 2018-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2019-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02831894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02831894, "The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02831894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*